These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16638866)

  • 1. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.
    Hong K; Khwaja A; Liapi E; Torbenson MS; Georgiades CS; Geschwind JF
    Clin Cancer Res; 2006 Apr; 12(8):2563-7. PubMed ID: 16638866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model.
    Namur J; Wassef M; Millot JM; Lewis AL; Manfait M; Laurent A
    J Vasc Interv Radiol; 2010 Feb; 21(2):259-67. PubMed ID: 20123210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion.
    Ridge JA; Collin C; Bading JR; Hancock C; Conti PS; Daly JM; Raaf JH
    Cancer Res; 1988 Aug; 48(16):4584-7. PubMed ID: 3396009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
    Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
    Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
    Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
    J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lattice intrahepatic doxorubicin with and without in-flow occlusion: a pharmacokinetic study of direct liver injection.
    Averbach A; Stuart OA; Chang D; Sugarbaker PH
    Eur J Surg Oncol; 2000 Feb; 26(1):73-9. PubMed ID: 10718184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.
    Vali M; Liapi E; Kowalski J; Hong K; Khwaja A; Torbenson MS; Georgiades C; Geschwind JF
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):95-101. PubMed ID: 17296709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 70-150-μm doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model.
    Gholamrezanezhad A; Mirpour S; Geschwind JF; Rao P; Loffroy R; Pellerin O; Liapi EA
    Eur Radiol; 2016 Oct; 26(10):3474-82. PubMed ID: 26780638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of intra-arterial chemotherapy combined with degradable starch microspheres against liver cancer--a study by experimental VX2 liver tumor model].
    Yoshikawa T; Itani K; Kokura S; Oyamada H; Kondo M
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1803-9. PubMed ID: 8379673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods.
    Weinberg BD; Ai H; Blanco E; Anderson JM; Gao J
    J Biomed Mater Res A; 2007 Apr; 81(1):161-70. PubMed ID: 17120197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment.
    Weinberg BD; Blanco E; Lempka SF; Anderson JM; Exner AA; Gao J
    J Biomed Mater Res A; 2007 Apr; 81(1):205-13. PubMed ID: 17120205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug.
    Fiume L; Baglioni M; Bolondi L; Farina C; Di Stefano G
    Drug Discov Today; 2008 Nov; 13(21-22):1002-9. PubMed ID: 18755287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spherex (degradable starch microspheres) chemo-occlusion--enhancement of tumor drug concentration and therapeutic efficacy: an overview.
    Håkansson L; Håkansson A; Morales O; Thorelius L; Warfving T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-100-S6-109. PubMed ID: 9151924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
    Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW
    J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fibrous capsule formation on doxorubicin distribution in radiofrequency ablated rat livers.
    Blanco E; Qian F; Weinberg B; Stowe N; Anderson JM; Gao J
    J Biomed Mater Res A; 2004 Jun; 69(3):398-406. PubMed ID: 15127386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants.
    Namur J; Citron SJ; Sellers MT; Dupuis MH; Wassef M; Manfait M; Laurent A
    J Hepatol; 2011 Dec; 55(6):1332-8. PubMed ID: 21703190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoembolization of liver cancer with doxorubicin-loaded CalliSpheres microspheres: plasma pharmacokinetics, intratumoral drug concentration, and tumor necrosis in a rabbit model.
    Liang B; Zhao D; Liu Y; Guo X; Zhang H; Zhang L; Zheng C
    Drug Deliv Transl Res; 2020 Feb; 10(1):185-191. PubMed ID: 31482517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
    Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
    Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.